Oxnard, Geoffrey R.
Eli Lilly and Company,
United States
2025 Rank: 43850
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dentistry
Rank in SubField 1: 1869 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43850 | 48327 |
| Total Cites | 18909 | 20787 |
| H-index | 62 | 66 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 73 | 75 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 4302 | 4574 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 8545 | 9167 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12938 | 13854 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.50 |
| Self-Citation Percentage |
9.03%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2024 Rank: 47727
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2066 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47727 | 52784 |
| Total Cites | 16442 | 18088 |
| H-index | 59 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 68 | 70 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 3985 | 4247 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 7769 | 8337 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11148 | 11953 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.51 |
| Self-Citation Percentage |
9.10%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2023 Rank: 52888
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2304 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52888 | 57708 |
| Total Cites | 14037 | 15440 |
| H-index | 54 | 57 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 62 | 64 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 3615 | 3860 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 6891 | 7412 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9516 | 10217 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.51 |
| Self-Citation Percentage |
9.09%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2022 Rank: 56933
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 2436 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56933 | 63887 |
| Total Cites | 11458 | 12656 |
| H-index | 50 | 52 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 56 | 58 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 3169 | 3395 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 5866 | 6319 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7845 | 8435 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.50 |
| Self-Citation Percentage |
9.47%
|
|
Oxnard, Geoffrey R.
Dana-Farber Cancer Institute,
United States
2021 Rank: 62994
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2664 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62994 | 69899 |
| Total Cites | 9830 | 10782 |
| H-index | 47 | 50 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 51 | 53 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 2931 | 3143 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 4965 | 5355 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6919 | 7379 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.46 |
| Self-Citation Percentage |
8.83%
|
|
Oxnard, Geoffrey R.
Dana-Farber Cancer Institute,
United States
2020 Rank: 82148
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3472 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82148 | 88567 |
| Total Cites | 7323 | 8085 |
| H-index | 37 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 41 | 43 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 2344 | 2524 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 3795 | 4118 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5198 | 5573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.45 |
| Self-Citation Percentage |
9.42%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.